We'll evaluate your injury, determine if BPC-157 is the right approach, and build a recovery protocol tailored to your situation
Frequently Asked Questions What is GHK-Cu peptide therapy
In a chronic social defeat stress model in mice, 21 days of oral administration at 0.1 mg/kg corrected depressive-like behavior, restored motor activity with a therapeutic effect of 60 percent, completely recovered anhedonia, restored synaptophysin levels (74 percent therapeutic effect), and fully restored CREB levels in the hippocampus
Together, they allow for broader experimental observation
As we age it becomes depleted resulting in fatigue, mental fog, lack of concentration, inflammation/oxidative stress, dull and tired looking skin, decreased endurance, and increased symptoms of chronic disease